Another systematic review 9 concluded that the use of GLP-1 agonist drugs was effective, safe and acceptablefor weight reduction and glucose control in children and adolescents with obesity.However, great caution is needed in considering this systematic review as a reliableevidence parameter. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.